Cronos Group Inc. (CRON)

Medicinal Chemicals & Botanical Products

Latest Price

$3.30

TTM P/E

17.37

Normalized P/E

Div Yield

Book Value

2.86

P/B Ratio

1.15

Valuation metrics

Base FCF: $3M (median of recent 5yr)

Growth: -15%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$2.22

33% downside

10.6% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
D. E. Shaw & Co., Inc.	8.84M	$24.0M	2.38%	+1.22M	2026-06-30
Tidal Investments LLC	3.77M	$10.0M	1.02%	-259.0K	2026-06-30
Dimensional Fund Advisors LP	3.05M	$8.0M	0.82%	+369.2K	2026-06-30
Arrowstreet Capital, Limited Partnership	1.99M	$5.0M	0.54%	+113.9K	2026-06-30
Renaissance Technologies LLC	1.74M	$4.0M	0.47%	-267.4K	2026-06-30
Mackenzie Financial Corp	1.60M	$6.0M	0.43%	+868.8K	2026-06-30
CIBC World Market Inc.	1.38M	$3.0M	0.37%	+36.5K	2026-06-30
Citadel Advisors LLC	1.28M	$3.0M	0.34%	+422.6K	2026-06-30
MMCAP International Inc. SPC	999.5K	$2.0M	0.27%	--	2026-06-30
Quinn Opportunity Partners LLC	969.0K	$2.0M	0.26%	--	2026-06-30